Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>β-cell dedifferentiation has been revealed as a pathological mechanism underlying pancreatic dysfunction in diabetes. We have previously shown that increased miR-7 levels trigger β-cell dedifferentiation and diabetes. We used β-cell-specific miR-7 overexpressing mice (Tg7) to test the hypothesis that loss of β-cell identity triggered by miR-7 overexpression alters islet gene expression and islet microenvironment in diabetes.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Method</h3><p>We performed bulk and single-cell RNA-Sequencing (RNA-seq) in islets obtained from β-cell-specific miR-7 overexpressing mice (Tg7). We carried out loss- and gain-of-function experiments in MIN6 and EndoC-βH1 cell lines. We analysed previously published mouse and human T2D datasets.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Βulk RNA-seq revealed that β-cell dedifferentiation is associated with the induction of genes associated with epithelial to mesenchymal transition (EMT) in pre-diabetic (2-week-old) and diabetic (12-week-old) Tg7 mice. Single-cell RNA-seq (scRNA-seq) indicated that this EMT signature is enriched specifically in β-cells. These molecular changes are associated with a weakening of β-cell:β-cell contacts, increased extracellular matrix (ECM) deposition and TGFβ-dependent islet fibrosis. We find that the mesenchymal reprogramming of β-cells is explained in part by the downregulation of <em>Pdx1</em> and its inability to regulate a myriad of epithelial-specific genes expressed in β-cells. Notable among genes transactivated by Pdx1 is <em>Ovol2</em>, which encodes a transcriptional repressor of the EMT transcription factor ZEB2. Following compromised β-cell identity, the reduction of <em>Pdx1</em> gene expression causes a decrease of <em>Ovol2</em> protein, thereby triggering mesenchymal reprogramming of β-cells through the induction of <em>Zeb2</em>. Finally, we provided evidence that EMT signalling associated with the upregulation of <em>Zeb2</em> expression is a molecular feature of islet of T2D subjects.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Our study indicates that miR-7-mediated β-cell dedifferentiation induces EMT signalling and a chronic response to tissue injury, which alters the islet microenvironment and predispose to fibrosis. This work suggests that regulators of EMT signalling may represent novel therapeutic targets for the treatment of β-cell dysfunction and fibrosis in T2D.</p>

Dysregulation of the Pdx1/Ovol2/Zeb2 axis in dedifferentiated β-cells triggers the induction of genes associated with epithelial–mesenchymal transition in diabetes

The miR-200-Zeb1 axis regulates key aspects of β-cell function and survival in vivo

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

Targeted Pharmacological Therapy Restores Beta-Cell Function For Diabetes Remission

The Polycomb-Dependent Epigenome Controls Β Cell Dysfunction, Dedifferentiation, and Diabetes.

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

339-OR: Enhanced Expression of Zinc Finger Protein 385D Leads to Type 2 Diabetes Phenotype in Human Beta Cells

Redox regulation of m 6 A methyltransferase METTL3 in β-cells controls the innate immune response in type 1 diabetes

Relationships between type 2 diabetes, cell dysfunction, and redox signaling: A meta-analysis of single-cell gene expression of human pancreatic α- and β-cells

Modeling human pancreatic beta cell dedifferentiation

Downregulation of Sirt3 contributes to β-cell dedifferentiation via FoxO1 in type 2 diabetic mellitus

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice

Differentially Expressed Genes Regulating Glutathione Metabolism, Protein-Folding, and Unfolded Protein Response in Pancreatic β-Cells in Type 2 Diabetes Mellitus

Identification of MDM2, YTHDF2 and DDX21 as potential biomarkers and targets for treatment of type 2 diabetes

Sel1L-Hrd1 ER-associated degradation maintains β cell identity via TGF-β signaling

Reversal of angiotensin ll-induced β-cell dedifferentiation via inhibition of NF-κb signaling

Single-Cell RNA-seq Analysis Reveals a Positive Correlation between Ferroptosis and Beta-Cell Dedifferentiation in Type 2 Diabetes

Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment